- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
ASCO® 2024 Insights: "NETTER-2 Study - Safety & TTR of [177Lu]Lu-DOTATATE in Pts With Newly Diagnosed Advanced Grade 2 & 3, Well-Differentiated Gastroenteropancreatic NETs"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Pamela Kunz
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Pamela Kunz
44 views
June 12, 2024
Chapters
NETTER-2 Study Overview & Key Differences
00:00
Safety & Time to Response in NETTER-2
01:54
Comments 0
Login to view comments.
Click here to Login
ASCO® 2024